Pulmonary Hypertension: Classification and Pathogenesis
Cystic Fibrosis: Management
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease-V: Management
Other Pulmonary Disorders
Cystic Fibrosis: Pathogenesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 18, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Katherine A Cheng1, Rose McNulty1, Holly Nichols1
1From the Department of Radiology (K.A.C., R.M., H.N., H.P.M., T.S.H.), Department of Pathology (J.C.), and Division of Pulmonary, Allergy, and Critical Care Medicine (A.S.), Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (A.T., E.C.); and Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, Calif (M.V.).
Familial pulmonary fibrosis (FPF) presents diagnostic challenges due to variable presentation and overlapping symptoms. Early diagnosis is crucial for better outcomes in FPF patients compared to sporadic cases.
06:03Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: